SCHEMBL23628441

SCHEMBL23628441

CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](C(C)CCCC(C)C)CC[C@H]4[C@@H]3C[C@@H](O)[C@@]2(N=[N+]=[N-])C1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NPC1L1 Q9UHC9 10/20 0.57
▸ USP2 O75604 3/20 0.55
▸ LMNA P02545 2/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ TP53 P04637 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ NPC1 O15118 1/20 0.52
▸ CDC25A P30304 4/20 0.48
▸ POLA1 P09884 1/20 0.47
▸ VDR P11473 1/20 0.46
▸ NFKB1 P19838 1/20 0.43
▸ NFKB2 Q00653 1/20 0.43
▸ RELA Q04206 1/20 0.43
▸ FNTA P49354 1/20 0.42
▸ FNTB P49356 1/20 0.42
▸ CDC25B P30305 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15301622 1.00 NPC1L1 (0.57) NPC1L1USP2LMNAMEN1TP53
SCHEMBL15301612 1.00 NPC1L1 (0.57) NPC1L1USP2LMNAMEN1TP53
SCHEMBL23628418 1.00 NPC1L1 (0.57) NPC1L1USP2LMNAMEN1TP53
SCHEMBL21814361 0.85 NPC1L1 (0.62) NPC1L1USP2LMNAMEN1TP53
SCHEMBL21814362 0.85 NPC1L1 (0.62) NPC1L1USP2LMNAMEN1TP53
SCHEMBL23628419 0.84 NPC1L1 (0.64) NPC1L1USP2LMNAMEN1TP53
SCHEMBL24032767 0.84 NPC1L1 (0.62) NPC1L1USP2LMNAMEN1TP53
SCHEMBL15301326 0.84 NPC1L1 (0.64) NPC1L1USP2LMNAMEN1TP53
SCHEMBL23628433 0.83 NPC1L1 (0.59) NPC1L1USP2LMNAMEN1TP53
SCHEMBL15301588 0.83 NPC1L1 (0.59) NPC1L1USP2LMNAMEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2625190-B1 DERIVATIVES OF STEROID BENZYLAMINES, HAVING AN ANTIPARASITIC, ANTIBACTERIAL, ANTIMYCOTIC AND/OR ANTIVIRAL ACTION UNIV JUSTUS LIEBIG GIESSEN (DE) 2021-07-14 — — EP disclosed
Send feedback